Yahoo
NasdaqCM - Delayed Quote USD

P3 Health Partners Inc. (PIII)

12.18 -4.29 (-26.05%)
At close: May 29 at 4:00:01 PM EDT
12.62 +0.44 (+3.61%)
After hours: May 29 at 7:58:15 PM EDT
Chart Range Bar
Loading chart for PIII
  • Previous Close 16.47
  • Open 16.35
  • Bid 8.73 x 200
  • Ask 15.48 x 200
  • Day's Range 12.01 - 16.54
  • 52 Week Range 1.52 - 16.89
  • Volume 200,834
  • Avg. Volume 1,287,511
  • Market Cap (intraday) 2.475B
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) --
  • EPS (TTM) -38.66
  • Earnings Date (est.) Aug 13, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 14.00

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.

p3hp.org

320

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 5/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PIII
249.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

PIII
68.93%
S&P 500 (^GSPC)
28.21%

3-Year Return

PIII
92.98%
S&P 500 (^GSPC)
80.24%

5-Year Return

PIII
97.54%
S&P 500 (^GSPC)
80.30%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 386.39M
Earnings --

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
100M
200M
300M

Analyst Insights

View More

Analyst Price Targets

14.00
14.00 Average
12.18 Current
14.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/22/2026
Analyst TD Cowen
Rating Action Maintains
Rating Hold
Price Action Raises
Price Target 3 -> 14

Statistics

View More

Valuation Measures

Annual
As of 5/29/2026
  • Market Cap

    40.51M

  • Enterprise Value

    337.68M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.04

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.23

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.14%

  • Return on Assets (ttm)

    -23.46%

  • Return on Equity (ttm)

    -6,952.57%

  • Revenue (ttm)

    1.46B

  • Net Income Avi to Common (ttm)

    -147.95M

  • Diluted EPS (ttm)

    -38.66

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.01M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    16.28M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

12.18 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: